HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alberto Roggi Selected Research

Alberto Roggi Research Topics

Disease

6Tuberculosis (Tuberculoses)
01/2021 - 01/2014
2Hearing Loss (Hearing Impairment)
01/2021 - 06/2020
2Ototoxicity
01/2021 - 06/2020
1Coinfection
06/2020
1Extensively Drug-Resistant Tuberculosis
01/2014

Drug/Important Bio-Agent (IBA)

3Rifampin (Rifampicin)FDA LinkGeneric
01/2021 - 01/2020
2Linezolid (Zyvox)FDA Link
01/2021 - 01/2014
2LopinavirFDA Link
06/2020 - 01/2020
2Rifabutin (Ansamycin)FDA Link
06/2020 - 01/2020
2Ritonavir (Norvir)FDA Link
06/2020 - 01/2020
1KanamycinFDA Link
06/2020
1lopinavir-ritonavir drug combination (Kaletra)FDA Link
01/2020
1pretomanidIBA
01/2014
1FluoroquinolonesIBA
01/2014
1bedaquiline (R207910)IBA
01/2014
1Anti-Bacterial Agents (Antibiotics)IBA
01/2014
1OPC-67683IBA
01/2014

Therapy/Procedure

3Injections
01/2021 - 01/2014